Cartesian Therapeutics Inc (NAS:RNAC)
$ 34.4 3.28 (10.43%) Market Cap: 612.18 Mil Enterprise Value: 466.55 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 46/100

Selecta Biosciences Inc Annual Shareholders Meeting Transcript

Jun 19, 2020 / 01:00PM GMT
Release Date Price: $90 (+11.11%)
Operator

Good day, and welcome to the Selecta Biosciences 2020 Annual Meeting of Stockholders. I would now like to turn the conference over to Carsten Brunn, President and Chief Executive Officer of Selecta Biosciences. Please go ahead.

Carsten Brunn
Selecta Biosciences, Inc. - CEO, President & Director

Thank you. Good morning, ladies and gentlemen. I'm Carsten Brunn, President and CEO of Selecta. I'd like to welcome you to our 2020 Annual Meeting of Stockholders, and thank you for your ongoing support of Selecta Biosciences.

I will act as Chairman of this meeting; and Elona Kogan, our General Counsel, will act as Secretary.

I'd like to first introduce to you the other members of the Board who are on the webcast today.

On the Board are Carrie Cox, the chair of the Board; Goran Ando, Tim Barabe, Scott Myers, Aymeric Sallin, Tim Springer and Patrick Zenner.

I'd like to also introduce Jason Janoff and [Maggie Yoo] of Ernst & Young, the company's independent auditor, who are available to respond to appropriate questions via

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot